Home
About Us
Certificate course in CRM
CRM Spotlight Buzz
CRM Live Events
Top 10 Papers
Contact
Home
About Us
Course
CRM Spotlight Buzz
CRM Live Events
Contact
Login
Join
Login
Join
Recommendation for glucose lowering treatment for patients with T2D and atherosclerotic CVD to reduce CVD risk
11 June 2024
Posted in
ESC Guidelines for Diabetes / Metabolic 2023
«
Previous
Next
»